Symptom Management for Irritable Bowel Syndrome
Not Applicable
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Other: Individualized protocolOther: Sham acupuncture/Placebo moxaOther: Standard protocol
- Registration Number
- NCT02079857
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 183
Inclusion Criteria
- Men and women 18 to 70 years of age.
- Diagnosis of IBS based on ROME III criteria.
- Complete symptom diaries and return completed diaries at all sessions.
Read More
Exclusion Criteria
- History of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology.
- Alarm symptoms according to ROME III.
- Individuals currently receiving other types of complementary therapies.
- Individuals with an acute medical condition requiring acute medical attention.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Individualized Individualized protocol Individualized protocol Control Sham acupuncture/Placebo moxa Sham acupuncture/Placebo moxa Standard Standard protocol Fixed protocol
- Primary Outcome Measures
Name Time Method Symptom severity-abdominal pain week 24
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NYU Division of Special Studies in Symptom Management
🇺🇸New York, New York, United States